Expanded intended use for D-dimer
Experience from the pandemic has shown D-dimer to be a prognostic marker for mortality in Covid-19 patients, as well as an aid in managing anticoagulant treatment in this group.
With support in scientific publications, we have now included this as an intended purpose for our D-dimer reagents. Accordingly, our D-dimer reagents can be used
- to exclude the presence of thrombosis in patients with suspected venous thromboembolism (VTE)
- as an aid in patient management in Covid-19 disease.